Peter Blackburn

A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.

H. Mulla, S. Frey, G. Gorse, 2022, Vaccine.

MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.

H. Mulla, S. Frey, G. Gorse, 2022, Vaccine.

An innovative partnership in management development

Peter Blackburn, B. Fryer, 1996 .